Cargando…

Patient blood management during the COVID–19 pandemic: a narrative review

As COVID–19 disease escalates globally, optimising patient outcome during this catastrophic healthcare crisis is the number one priority. The principles of patient blood management are fundamental strategies to improve patient outcomes and should be given high priority in this crisis situation. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Baron, D. M., Franchini, M., Goobie, S. M., Javidroozi, M., Klein, A. A., Lasocki, S., Liumbruno, G. M., Muñoz, M., Shander, A., Spahn, D. R., Zacharowski, K., Meybohm, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497056/
https://www.ncbi.nlm.nih.gov/pubmed/32339260
http://dx.doi.org/10.1111/anae.15095
_version_ 1783583234536243200
author Baron, D. M.
Franchini, M.
Goobie, S. M.
Javidroozi, M.
Klein, A. A.
Lasocki, S.
Liumbruno, G. M.
Muñoz, M.
Shander, A.
Spahn, D. R.
Zacharowski, K.
Meybohm, P.
author_facet Baron, D. M.
Franchini, M.
Goobie, S. M.
Javidroozi, M.
Klein, A. A.
Lasocki, S.
Liumbruno, G. M.
Muñoz, M.
Shander, A.
Spahn, D. R.
Zacharowski, K.
Meybohm, P.
author_sort Baron, D. M.
collection PubMed
description As COVID–19 disease escalates globally, optimising patient outcome during this catastrophic healthcare crisis is the number one priority. The principles of patient blood management are fundamental strategies to improve patient outcomes and should be given high priority in this crisis situation. The aim of this expert review is to provide clinicians and healthcare authorities with information regarding how to apply established principles of patient blood management during the COVID–19 pandemic. In particular, this review considers the impact of the COVID–19 pandemic on blood supply and specifies important aspects of donor management. We discuss how preventative and control measures implemented during the COVID–19 crisis could affect the prevalence of anaemia, and highlight issues regarding the diagnosis and treatment of anaemia in patients requiring elective or emergency surgery. In addition, we review aspects related to patient blood management of critically ill patients with known or suspected COVID–19, and discuss important alterations of the coagulation system in patients hospitalised due to COVID–19. Finally, we address special considerations pertaining to supply‐demand and cost‐benefit issues of patient blood management during the COVID–19 pandemic.
format Online
Article
Text
id pubmed-7497056
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74970562020-09-25 Patient blood management during the COVID–19 pandemic: a narrative review Baron, D. M. Franchini, M. Goobie, S. M. Javidroozi, M. Klein, A. A. Lasocki, S. Liumbruno, G. M. Muñoz, M. Shander, A. Spahn, D. R. Zacharowski, K. Meybohm, P. Anaesthesia Review Articles As COVID–19 disease escalates globally, optimising patient outcome during this catastrophic healthcare crisis is the number one priority. The principles of patient blood management are fundamental strategies to improve patient outcomes and should be given high priority in this crisis situation. The aim of this expert review is to provide clinicians and healthcare authorities with information regarding how to apply established principles of patient blood management during the COVID–19 pandemic. In particular, this review considers the impact of the COVID–19 pandemic on blood supply and specifies important aspects of donor management. We discuss how preventative and control measures implemented during the COVID–19 crisis could affect the prevalence of anaemia, and highlight issues regarding the diagnosis and treatment of anaemia in patients requiring elective or emergency surgery. In addition, we review aspects related to patient blood management of critically ill patients with known or suspected COVID–19, and discuss important alterations of the coagulation system in patients hospitalised due to COVID–19. Finally, we address special considerations pertaining to supply‐demand and cost‐benefit issues of patient blood management during the COVID–19 pandemic. John Wiley and Sons Inc. 2020-05-06 2020-08 /pmc/articles/PMC7497056/ /pubmed/32339260 http://dx.doi.org/10.1111/anae.15095 Text en © 2020 The Authors. Anaesthesia published by John Wiley & Sons Ltd on behalf of Association of Anaesthetists This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Review Articles
Baron, D. M.
Franchini, M.
Goobie, S. M.
Javidroozi, M.
Klein, A. A.
Lasocki, S.
Liumbruno, G. M.
Muñoz, M.
Shander, A.
Spahn, D. R.
Zacharowski, K.
Meybohm, P.
Patient blood management during the COVID–19 pandemic: a narrative review
title Patient blood management during the COVID–19 pandemic: a narrative review
title_full Patient blood management during the COVID–19 pandemic: a narrative review
title_fullStr Patient blood management during the COVID–19 pandemic: a narrative review
title_full_unstemmed Patient blood management during the COVID–19 pandemic: a narrative review
title_short Patient blood management during the COVID–19 pandemic: a narrative review
title_sort patient blood management during the covid–19 pandemic: a narrative review
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497056/
https://www.ncbi.nlm.nih.gov/pubmed/32339260
http://dx.doi.org/10.1111/anae.15095
work_keys_str_mv AT barondm patientbloodmanagementduringthecovid19pandemicanarrativereview
AT franchinim patientbloodmanagementduringthecovid19pandemicanarrativereview
AT goobiesm patientbloodmanagementduringthecovid19pandemicanarrativereview
AT javidroozim patientbloodmanagementduringthecovid19pandemicanarrativereview
AT kleinaa patientbloodmanagementduringthecovid19pandemicanarrativereview
AT lasockis patientbloodmanagementduringthecovid19pandemicanarrativereview
AT liumbrunogm patientbloodmanagementduringthecovid19pandemicanarrativereview
AT munozm patientbloodmanagementduringthecovid19pandemicanarrativereview
AT shandera patientbloodmanagementduringthecovid19pandemicanarrativereview
AT spahndr patientbloodmanagementduringthecovid19pandemicanarrativereview
AT zacharowskik patientbloodmanagementduringthecovid19pandemicanarrativereview
AT meybohmp patientbloodmanagementduringthecovid19pandemicanarrativereview